ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Intarcia Therapeutics clinical trials

Also known as BioMedicines.

The registry lists 22 studies whose lead sponsor is Intarcia Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 7, 2019.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

What it is testing

The drugs Intarcia Therapeutics’ studies test, most studies first; none is open now — 11 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 1 more

All 22 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1464%
  • Stopped early836%Terminated 5 · Withdrawn 3

Phase

  • Phase 313
  • Phase 17
  • Phase 22

Where

  • United States20
  • Russian Federation4
  • Canada3
  • Ukraine3
  • Germany3
  • Bulgaria2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 713
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 6 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Intarcia Therapeutics.

  • Intarcia Therapeutics
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies
  • BioMedicines
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Focus areas

Conditions Intarcia Therapeutics leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 22 of 22.